10/09 - Dr. Ruskin Joins PKC Board
DR. JEREMY N. RUSKIN JOINS PKC BOARD OF DIRECTORS
INGLEWOOD, CALIFORNIA, October 8, 2009 - Pharmaco-Kinesis Corporation (PKC), an advanced medical device company developing smart local drug delivery systems, today reported that Dr Jeremy N. Ruskin, M.D., Director, Cardiac Arrhythmia Service, Massachusetts General Hospital and Associate Professor of Medicine, Harvard Medical School, has joined the Company's Board of Directors.
Dr. Ruskin obtained his medical degree from Harvard Medical School and currently directs the Cardiac Arrhythmia Service at Massachusetts General Hospital.
is a recipient of the Pioneer in Cardiac Pacing and Electrophysiology Award from the Heart Rhythm Society
groundbreaking contributions to the field of cardiac arrhythmias and clinical cardiac electrophysiology.
"The strength of Pharmaco-Kinesis
is founded on three pillars, intellectual property, smart drug delivery technology and clinical relevance.
Dr Ruskin will bring invaluable expertise in advancing the clinical relevance of our products as we proceed to human trials," said Frank Adell, CEO of PKC.
"The PKC Board welcomes Dr. Ruskin and looks forward to his leadership in expanding our presence among major medical centers in the US and abroad."